TP53 and carcinoma: In another study carried out by comparing low-grade and high-grade serous ovarian carcinoma, infrequent TP53 mutations in low-grade carcinomas were shown, whereas the mutations were ubiquitous in high-grade serous ovarian carcinoma, in which 100% TP53 mutations were demonstrated [33].